Loading...
Loading...
India's protein imports from CHINA total $40.5M across 1,170 shipments from 15 foreign suppliers. CN-GEN MAB CO LIMITED leads with $38.5M in import value; the top 5 suppliers together control 99.1% of this origin. Leading Indian buyers include CIPLA LIMITED. This corridor reflects India's pharmaceutical import demand for protein — a diversified sourcing base with multiple active suppliers from CHINA.

CN-GEN MAB CO LIMITED is the leading Protein supplier from CHINA to India, with import value of $38.5M across 1 shipments. The top 5 suppliers — CN-GEN MAB CO LIMITED, SINO BIOLOGICAL INC., FAPON INTERNATIONAL LIMITED, QILU PHARMACEUTICAL HAINAN CO LIMITED, SINO BIOLOGICAL INC — collectively account for 99.1% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CN-GEN MAB CO LIMITED | $38.5M | 1 | 95.1% |
| 2 | SINO BIOLOGICAL INC. | $805.7K | 123 | 2.0% |
| 3 | FAPON INTERNATIONAL LIMITED | $358.3K | 70 | 0.9% |
| 4 | QILU PHARMACEUTICAL HAINAN CO LIMITED | $241.4K | 2 | 0.6% |
| 5 | SINO BIOLOGICAL INC | $215.5K | 359 | 0.5% |
| 6 | SENBT CO., LTD. | $49.9K | 25 | 0.1% |
| 7 | FAPON INTERNATIONAL LIMITED. | $42.1K | 33 | 0.1% |
| 8 | SHENZHEN YHLO BIOTECH CO., LTD | $27.9K | 18 | 0.1% |
| 9 | CENTERICH BIO-PHARM INTERNATIONAL HOLDINGS LIMITED | $20.4K | 1 | 0.1% |
| 10 | SENBT CO. LTD | $18.6K | 11 | 0.0% |
| 11 | FAPON INTERNATIONAL LTD | $16.6K | 15 | 0.0% |
| 12 | SENBT CO LIMITED | $16.1K | 8 | 0.0% |
| 13 | GENRUI BIOTECH INC | $15.4K | 2 | 0.0% |
| 14 | SENBT CO., LTD | $13.6K | 32 | 0.0% |
| 15 | CLOUD-CLONE CORP | $11.5K | 3 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED | $38.5M | 1 | 95.1% |
| 2 | KRISHGEN BIOSYSTEMS | $1.0M | 511 | 2.6% |
| 3 | MERIL DIAGNOSTICS PRIVATE LIMITED | $264.2K | 70 | 0.7% |
| 4 | CLIANTHA RESEARCH LIMITED | $241.4K | 2 | 0.6% |
| 5 | ASPEN LABORATORIES PRIVATE LIMITED | $65.7K | 32 | 0.2% |
| 6 | BHAT BIO-TECH INDIA PRIVATE LIMITED | $41.5K | 16 | 0.1% |
| 7 | CPC DIAGNOSTICS PRIVATE LIMITED | $32.7K | 24 | 0.1% |
| 8 | RECOMBIGEN LABORATORIES PRIVATE LIMITED | $30.2K | 14 | 0.1% |
| 9 | LABGENE BIO-TECH PRIVATE LIMITED | $22.6K | 5 | 0.1% |
| 10 | BIOLINE DIAGNOSTICS LLP | $21.8K | 12 | 0.1% |
| 11 | MEDSOURCE OZONE BIOMEDICALS PRIVATE LIMITED | $20.6K | 15 | 0.1% |
| 12 | URIHK PHARMACEUTICAL PRIVATE LIMITED | $20.4K | 1 | 0.1% |
| 13 | DEEP MEDITECH PRIVATE LIMITED | $20.0K | 5 | 0.0% |
| 14 | PATHKITS HEALTHCARE PRIVATE LIMITED | $18.6K | 11 | 0.0% |
| 15 | SUNNY CORPORATION PRIVATE LIMITED | $18.6K | 7 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Protein suppliers from CHINA to India include CN-GEN MAB CO LIMITED, SINO BIOLOGICAL INC., FAPON INTERNATIONAL LIMITED. The leading supplier is CN-GEN MAB CO LIMITED with import value of $38.5M USD across 1 shipments. India imported Protein worth $40.5M USD from CHINA in total across 1,170 shipments.
India imported Protein worth $40.5M USD from CHINA across 1,170 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Protein sourced from CHINA include CIPLA LIMITED, KRISHGEN BIOSYSTEMS, MERIL DIAGNOSTICS PRIVATE LIMITED. The largest buyer is CIPLA LIMITED with $38.5M in imports across 1 shipments.
The total value of Protein imports from CHINA to India is $40.5M USD, across 1,170 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,170 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists